| Total (n = 35) | BTT (n = 19) | BTR (n = 16) |
---|---|---|---|
Age (mean ± SD) | 45.2 ± 18.7 | 43.4 ± 13.2 | 47.4 ± 23.9 |
Female (n, %) | 20 (57) | 11 (59) | 9 (56) |
Diagnosis (n, %) | Â | Â | Â |
   CF | 10 (29) | 10 (53) | 0 |
   ARDS | 9 (26) | NA | 9 (56) |
   ILD | 6 (17) | 6 (32) | 0 |
   COPD | 6 (17) | 2 (11) | 4 (25) |
   PAH | 4 (11) | 1 (5) | 3 (19) |
APACHE II (mean ± SD) | 24.3 ± 7.8 | 20.4 ± 5.8 | 28.8 ± 7.5 |
Pre-ECMO PaO2: FIO2 ratio in hypoxemic patients (mm Hg, mean ± SD) | 58.3 ± 13.1 | 62.0 ± 12.2 | 55.0 ± 13.5 |
Pre-ECMO pH in hypercapnic patients (mean ± SD) | 7.21 ± 0.13 | 7.24 ± 0.10 | 7.15 ± 0.17 |
Pre-ECMO PaCO2 in hypercapnic patients (mean ± SD) | 96.3 ± 27.2 | 105.5 ± 27.9 | 81 ± 19.3 |
Venovenous ECMO via dual-lumen catheter (n, %) | 23 (66) | 14 (74) | 9 (56) |
Venoarterial ECMO via subclavian artery and internal jugular vein (n, %) | 4 (11) | 3 (16) | 1 (6) |
Femoral cannulation (n, %) | 8 (23) | 2 (11) | 6 (38) |